A private company advising the agency that oversees Medicare has recommended against reimbursing for the biomarker tests, sparking a backlash from cancer specialists.LeeAnne Loney.Courtesy of LeeAnn LoneyJuly 4, 2026, 6:00 AM EDTBy Gretchen MorgensonLeeAnne Loney was facing an excruciating decision in the summer of 2024. Just a moment.We are getting your experience ready.
Millions of women may lose Medicare coverage for a breast cancer test hailed by doctors
A private company advising the agency that oversees Medicare has recommended against reimbursing for the biomarker tests, sparking a backlash from cancer specialists.
53 words~1 min read
